NeuroPace Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	69.07	65.42	45.52	45.18	41.14	36.97
Revenue Growth (YoY)	42.07%	43.72%	0.75%	9.83%	11.27%	-
Cost of Revenue	17.98	17.3	13.03	11.75	10.87	10.51
Gross Profit	51.09	48.12	32.49	33.44	30.27	26.46
Selling, General & Admin	56.19	54.52	51.34	38.96	27.63	30.2
Research & Development	21.3	20.78	21.95	18.21	15.7	18.29
Operating Expenses	77.49	75.3	73.29	57.17	43.32	48.5
Operating Income	-26.4	-27.17	-40.79	-23.74	-13.05	-22.03
Interest Expense / Income	8.81	8.52	7.53	7.41	11.49	9.49
Other Expense / Income	-3.7	-2.74	-1.24	4.93	-0.26	-1.54
Pretax Income	-31.51	-32.96	-47.08	-36.08	-24.28	-29.97
Net Income	-31.51	-32.96	-47.08	-36.08	-24.28	-29.97
Shares Outstanding (Basic)	28	26	25	17	0	0
Shares Outstanding (Diluted)	28	26	25	17	0	0
Shares Change	12.70%	5.11%	48.08%	8038.86%	1.06%	-
EPS (Basic)	-1.18	-1.27	-1.91	-2.17	-117.85	-148.44
EPS (Diluted)	-1.18	-1.27	-1.91	-2.17	-117.85	-148.44
Free Cash Flow	-17.68	-19.87	-37.47	-24.96	-21.67	-25.49
Free Cash Flow Per Share	-0.63	-0.77	-1.52	-1.50	-106.19	-126.23
Gross Margin	73.97%	73.56%	71.38%	74.00%	73.59%	71.58%
Operating Margin	-38.22%	-41.54%	-89.62%	-52.54%	-31.72%	-59.59%
Profit Margin	-45.61%	-50.38%	-103.43%	-79.85%	-59.02%	-81.07%
Free Cash Flow Margin	-25.59%	-30.38%	-82.32%	-55.24%	-52.68%	-68.94%
EBITDA	-21.06	-22.83	-36.57	-28.37	-12.48	-20.07
EBITDA Margin	-30.49%	-34.90%	-80.33%	-62.80%	-30.34%	-54.28%
Depreciation & Amortization	1.63	1.61	2.99	0.3	0.31	0.42
EBIT	-22.7	-24.44	-39.55	-28.67	-12.79	-20.49
EBIT Margin	-32.86%	-37.36%	-86.89%	-63.45%	-31.10%	-55.41%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).